Pharming Group announces the filing of its 2025 Annual Report and Form 20-F
Financial updatesPharming Group N.V. today announced the filing of its Annual Report for the year ended December 31, 2025.
2026
Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow
Financial updatesPharming Group N.V. presents its preliminary (unaudited) financial report for the three months and full year ended December 31, 2025.
Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
Financial updatesPharming Group N.V. confirms that it will report its preliminary (unaudited) financial results for the fourth quarter and full year 2025 and provide a business update on Thursday, March 12, 2026.
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
Financial updatesPharming Group N.V. today announced 2026 financial guidance and will highlight its advancing clinical-stage rare disease pipeline, including two major value-creating programs, at a virtual Investor Day taking place later today.
Pharming Group reports preliminary 2025 revenues and announces Investor Day
Financial updatesPharming Group N.V. today announced its preliminary, unaudited revenues for the full year 2025 and plans to host a virtual Investor Day on February 3, 2026, at 10:00 am EST (16:00 CET).
2025
Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow
Financial updatesPharming Group N.V. presents its preliminary (unaudited) financial report for the three months ended September 30, 2025.
Pharming Group to report third quarter 2025 financial results and provide business update on November 6
Financial updatesPharming Group N.V. confirms that it will report its preliminary (unaudited) financial results for the third quarter 2025 and provide a business update on Thursday, November 6, 2025.
Pharming Group reports second quarter and first half 2025 financial results and provides business update
Financial updatesPharming Group N.V. presents its preliminary (unaudited) financial report for the second quarter and first half year ended June 30, 2025.
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
Financial updatesPharming Group N.V. confirms that it will report its preliminary (unaudited) financial results for the second quarter and first half 2025 and provide a business update on Thursday, July 31, 2025.
Pharming Group reports first quarter 2025 financial results and provides business update
Financial updatesPharming Group N.V. presents its preliminary unaudited financial report for the three months ended March 31, 2025.